november 22, 2016
BIOPHYTIS received regulatory authorizations to conduct SARA-OBS study in sarcopenia patients. Read the Press Release
BIOPHYTIS received regulatory authorizations to conduct SARA-OBS study in sarcopenia patients. Read the Press Release